Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,862 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Yoshikawa T, Terashima M, Mizusawa J, Nunobe S, Nishida Y, Yamada T, Kaji M, Nomura T, Hato S, Choda Y, Yabusaki H, Yoshida K, Misawa K, Masuzawa T, Tsuda M, Kawachi Y, Katayama H, Fukuda H, Kurokawa Y, Boku N, Sano T, Sasako M. Yoshikawa T, et al. Among authors: yoshida k. Gastric Cancer. 2024 Jan;27(1):155-163. doi: 10.1007/s10120-023-01447-5. Epub 2023 Nov 21. Gastric Cancer. 2024. PMID: 37989806 Clinical Trial.
A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma.
Yoshikawa T, Tsuburaya A, Hirabayashi N, Yoshida K, Nagata N, Kodera Y, Takahashi N, Oba K, Kimura M, Ishikura S, Miyashita Y, Sakamoto J. Yoshikawa T, et al. Among authors: yoshida k. Cancer Chemother Pharmacol. 2009 Nov;64(6):1071-7. doi: 10.1007/s00280-009-0963-3. Epub 2009 Mar 13. Cancer Chemother Pharmacol. 2009. PMID: 19283353 Clinical Trial.
A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II).
Tsuburaya A, Morita S, Kodera Y, Kobayashi M, Shitara K, Yamaguchi K, Yoshikawa T, Yoshida K, Yoshino S, Sakamoto J. Tsuburaya A, et al. Among authors: yoshida k. BMC Cancer. 2012 Jul 23;12:307. doi: 10.1186/1471-2407-12-307. BMC Cancer. 2012. PMID: 22824079 Free PMC article. Clinical Trial.
[A case of intrahepatic cholangiocarcinoma with peritoneal dissemination treated successfully with surgical resection and adjuvant chemotherapy].
Shiozaki S, Satoh D, Matsukawa H, Yamaguchi K, Takahashi K, Mimura N, Taguchi K, Araki H, Toshima T, Kato T, Miyake S, Miyoshi H, Yoshida K, Choda Y, Tokumoto N, Kanazawa T, Harano M, Ojima Y, Idani H, Okajima M, Ninomiya M. Shiozaki S, et al. Among authors: yoshida k. Gan To Kagaku Ryoho. 2014 Nov;41(12):2089-91. Gan To Kagaku Ryoho. 2014. PMID: 25731432 Japanese.
11,862 results
You have reached the last available page of results. Please see the User Guide for more information.